Literature DB >> 24384027

Freeze drying: exploring potential in development of orodispersible tablets of sumatriptan succinate.

Dalapathi Gugulothu1, Preshita Desai, Pranav Pandharipande, Vandana Patravale.   

Abstract

The present investigation is aimed at development and characterization of sumatriptan succinate orodispersible tablets (ODTs) prepared by freeze drying technology. The tablet excipients were screened and the composition was optimized based on parameters which involved general appearance, tablet size and shape, uniformity of weight, mechanical properties, surface pH, moisture analysis, drug content, wetting time, in vitro and in vivo disintegration time. Furthermore, fourier transform infrared spectroscopy, differential scanning calorimetry, scanning electron micrograph of cross-section of the tablet and in vitro dissolution studies were performed. Studies revealed that formulation containing gelatin-mannitol (3.75% w/v and 3.5% w/v, respectively) with camphor as a volatile pore forming agent exhibited superior properties with disintegration time of less than 10 s. Furthermore, in vitro release studies revealed 90% release of drug from developed dosage form within 10 min, thus suggesting rapid drug dissolution followed by faster onset of action, which forms a strong rationale for development of ODTs of sumatriptan succinate. The developed technology is simple, which involves few steps and can be easily scaled up. Thus, it holds enormous potential for commercial exploitation.

Entities:  

Keywords:  Gelatin; in vitro disintegration time; in vitro drug release; lyophilization technology; scanning electron microscopic analysis

Mesh:

Substances:

Year:  2014        PMID: 24384027     DOI: 10.3109/03639045.2013.871551

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  3 in total

1.  Characterization and in vivo efficacy of a heptapeptide ODT formulation for the treatment of neurogenic bladder dysfunction.

Authors:  Jungeun Bae; Thomas A Johnston; Rungsiri Chaiittianan; Khaetthareeya Sutthanut; Michael Jay; Lesley Marson
Journal:  Int J Pharm       Date:  2017-11-28       Impact factor: 5.875

2.  'Tablet-in-Syringe': A Novel Dosing Mechanism for Dysphagic Patients Containing Fast-Disintegrating Tablets Fabricated Using Semisolid Extrusion 3D Printing.

Authors:  Pattaraporn Panraksa; Bin Zhang; Pornchai Rachtanapun; Kittisak Jantanasakulwong; Sheng Qi; Pensak Jantrawut
Journal:  Pharmaceutics       Date:  2022-02-18       Impact factor: 6.321

3.  Milk Oral Lyophilizates with Loratadine: Screening for New Excipients for Pediatric Use.

Authors:  Sonia Iurian; Cătălina Bogdan; Ștefana Suciu; Dana-Maria Muntean; Lucia Rus; Mihaela Berindeie; Szidonia Bodi; Rita Ambrus; Ioan Tomuță
Journal:  Pharmaceutics       Date:  2022-06-24       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.